gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS)
ROCKAWAY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...
Source: globenewswire.com
Stay updated with breaking news from Eric Liebler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ROCKAWAY, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced...
Clinical Trial (n=69) suggests safety and feasibility of nVNS for the acute treatment of stroke. Relative Ischemic Lesion Growth Decreased by 65.9% with...
GuruFocus Article or News written by GuruFocusNews and the topic is about:
NVNS reduces symptoms of PTSD by 31% in sham-controlled study...
GuruFocus Article or News written by GuruFocusNews and the topic is about: